These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 8782126)
1. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. Lovy MR; Starkebaum G; Uberoi S J Rheumatol; 1996 Jun; 23(6):979-83. PubMed ID: 8782126 [TBL] [Abstract][Full Text] [Related]
2. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797 [TBL] [Abstract][Full Text] [Related]
3. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China. Zhang X; Li H; Li T; Zhang F; Han Y J Rheumatol; 2007 Aug; 34(8):1760-4. PubMed ID: 17659750 [TBL] [Abstract][Full Text] [Related]
4. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. Nikolaisen C; Rekvig OP; Nossent HC Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159 [TBL] [Abstract][Full Text] [Related]
5. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related]
6. [Screening of patients at risk for hepatitis C virus infection in general medicine]. Altman C; Lesiour A; Dunbavand A; Meyer L; de la Selle P; Buffet C Gastroenterol Clin Biol; 1999 Mar; 23(3):359-62. PubMed ID: 10384340 [TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis in Congo-Brazzaville. A study of thirty-six cases. Bileckot R; Malonga AC Rev Rhum Engl Ed; 1998 May; 65(5):308-12. PubMed ID: 9636949 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Cojocaru M; Cojocaru IM; Iacob SA Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159 [TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C virus infection presenting as a polyarthritis: report of 2 cases]. Cáceres N; Cerda M; Ribalta J; Wainstein E Rev Med Chil; 1997 Nov; 125(11):1357-60. PubMed ID: 9609058 [TBL] [Abstract][Full Text] [Related]
13. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353 [TBL] [Abstract][Full Text] [Related]
14. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
15. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453 [TBL] [Abstract][Full Text] [Related]
17. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
18. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
19. Recent onset arthritis in the elderly: a 5 year longitudinal observational study. Glennås A; Kvien TK; Andrup O; Karstensen B; Munthe E J Rheumatol; 2000 Jan; 27(1):101-8. PubMed ID: 10648025 [TBL] [Abstract][Full Text] [Related]
20. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]